Literature DB >> 24021246

Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection.

Chiara Giannitti1, Irene Fineschi, Bruno Frediani, Antonella Fioravanti, Mauro Galeazzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24021246

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  2 in total

1.  Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice.

Authors:  Ying-Qian Mo; An-Qi Liang; Jian-Da Ma; Le-Feng Chen; Dong-Hui Zheng; H Ralph Schumacher; Lie Dai
Journal:  BMC Musculoskelet Disord       Date:  2014-12-22       Impact factor: 2.362

2.  Prevalence of past and reactivated viral infections and efficacy of cyclosporine A as monotherapy or in combination in patients with psoriatic arthritis--synergy study: a longitudinal observational study.

Authors:  Delia Colombo; Sergio Chimenti; Paolo Grossi; Antonio Marchesoni; Sergio Di Nuzzo; Vito Griseta; Anna Gargiulo; Aurora Parodi; Lucia Simoni; Gilberto Bellia
Journal:  Biomed Res Int       Date:  2014-04-03       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.